06:08 AM EDT, 10/09/2025 (MT Newswires) -- US President Donald Trump's administration is not planning to impose tariffs on generic drugs from foreign countries, The Wall Street Journal reported late Wednesday, citing a White House spokesman as saying in a statement.

"The administration is not actively discussing imposing Section 232 tariffs against generic pharmaceuticals," the report said, citing White House spokesman Kush Desai.

The US Department of Commerce also said that the generic drugs will be excluded from the tariff plan, the journal said.

The decision is not final and may change in the coming weeks, according to the media outlet.

The White House did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)